A one-year course of abatacept treatment delayed the onset of rheumatoid arthritis by up to four years in people at high risk, with benefits lasting after treatment ended. The King's College London study offers important evidence for immune-targeted early intervention.
Three studies presented at ASCO 2026 suggest GLP-1 class weight-loss drugs can reduce the risk of developing or dying from breast cancer by up to 30 percent. The findings open debate over whether the jabs should join the cancer-fighting toolkit.
A global coalition led by CEPI has announced 62 million dollars in funding to fast-track three vaccine candidates against the growing Ebola outbreak in Congo, where no licensed vaccine currently exists. The effort targets the Bundibugyo strain.
A new daily pill, daraxonrasib, has doubled survival time for patients with pancreatic cancer, one of the deadliest forms of the disease. According to phase 3 data presented at ASCO 2026, the treatment increased median survival from 4.4 to 8.6 months.
Science Daily reports a sweeping global analysis finding chronic kidney disease now affects nearly 800 million people and is one of the leading causes of death worldwide. Often silent in its early stages, the condition is also a major contributor to heart disease and may be more prevalent than current estimates suggest.
Guardian Health reports that the first clinical trial of its kind, involving 410 cancer survivors in the United States, has found that regular yoga sessions produce significant reductions in anxiety, insomnia, distress and fatigue. Researchers said yoga could serve as a complementary approach in post-cancer care.
STAT News reports that the world's largest cancer research meeting closed with sessions focused on barriers to care, Merkel cell carcinoma readouts, GLP-1 medicines in cancer prevention, and Grail's multi-cancer early detection blood test. Attendance crossed 47,000 in person and online.
Guardian Health reports that a UK modernisation bill requiring NHS GPs and hospitals to share patient records could prevent up to 20,000 A&E visits a year, ministers claim. The proposal also aims to reduce medical errors and duplication of investigations within NHS England.
According to Science Daily, researchers at Scripps Research have identified a molecular 'switch' that sustains brain inflammation in Alzheimer's. A protein called STING undergoes a chemical change that keeps the immune response locked on.
According to The Guardian, two large new studies suggest that poor sleep patterns may be contributing to rising cancer diagnoses among adults under 50. Early-onset cancer cases have risen sharply across recent decades.
STAT News reports that a phase 3 trial in India showed low-dose nivolumab extended survival in patients with head and neck squamous cell carcinoma. The result could open wider access to high-tech immunotherapies for patients in lower-income countries.
BBC reports that experts have highlighted screening findings showing that sudden cardiac death is not only a hazard for active young men. 'Silent' heart-rhythm conditions in young women may underlie traumatic losses families struggle to accept.
Resident doctors in England will strike for a 16th time over pay, with the British Medical Association (BMA) announcing a new four-day stoppage beginning 15 June. The action revives concerns about delays in elective care across the NHS, BBC Health reports.
Science Daily reports a new study suggesting that melatonin supplements may help night shift workers boost their body's DNA repair processes. The pilot research is early but raises the possibility of a simple strategy to reduce long-term health risks linked to night work.
California-based Revolution Medicines has begun early-access shipping of its experimental pancreatic cancer drug daraxonrasib, with CEO Mark Goldsmith telling STAT News the company intends to submit it for FDA approval soon. Investigators at ASCO 2026 cited positive phase 1-2 data as the basis for optimism.
The Guardian reports that a triple-action cancer immunotherapy has produced 'unprecedented' responses in patients whose disease had become resistant to chemotherapy and immunotherapy, fully eradicating tumours in some cases. Findings were presented at the American Society of Clinical Oncology (ASCO) annual meeting.
A new imaging study led by Massachusetts General Hospital has shown that the brain-inflammation signatures previously predicted in long COVID patients are not present. The findings call for a re-evaluation of the cognitive dysfunction mechanism.
In an international study reported by the Guardian, the OncoMasTR genomic test has been shown to safely eliminate chemotherapy requirements in a significant portion of early-stage breast cancer patients. The study enrolled 5,000 patients across 30 countries.
According to STAT News, Massachusetts Attorney General Andrea Campbell has filed suit against UnitedHealth Group alleging approximately $100 million in 'medical upcoding' fraud. The case is the latest in regulatory scrutiny of the senior-care business at the largest US health insurer.
According to STAT News, Bristol Myers Squibb presented positive Phase 3 results for combination therapy in multiple myeloma on the first day of the ASCO Annual Meeting. Pfizer reported significant progress on its anti-CEACAM5 ADC therapy in non-small cell lung cancer.
Cambridge University researchers reversed adult nerve cells' lost capacity to regrow in lab-built miniature brain-and-spinal-cord systems by using an existing hormone drug. The study opens a potential treatment pathway for nerve damage previously considered irreversible.
Scientists have published new research showing that cannabidiol (CBD) reduces neuroinflammation in mouse models of Alzheimer's disease by calming the brain's immune response. Inhaled CBD reduced key drivers linked to memory loss and brain degeneration; human clinical trials have not begun.
Alan Milburn, the Blair-era cabinet minister turned social mobility adviser, has released the first part of his report on the nearly 1 million 16- to 24-year-olds in the UK outside education, employment or training (NEET). According to the Guardian, the 217-page report sets out structural issues that Milburn calls 'a record of failure.'
The United States has issued travel and quarantine restrictions in response to the spreading Ebola outbreak in the Democratic Republic of the Congo (DRC). According to STAT News, the new policies may discourage volunteer health workers from responding to the outbreak while creating risks for Americans infected overseas.
Science Daily reports that ION224, an experimental drug developed at UC San Diego, has shown promising clinical results for MASH (metabolic dysfunction-associated steatohepatitis), a serious fatty liver disease that affects millions of people worldwide.
Guardian Health reports that 10,406 salmonella cases were recorded in England last year, the highest figure since 2016. Experts are drawing links between the rise and climate change, temperature increases and shifts in the food chain.
STAT News reports that an experimental GSK drug for chronic hepatitis B achieved a 'functional cure' in about one in five patients in clinical trial data, an outcome that substantially outpaces current treatments.
BBC Health reports that the UK National Screening Committee has recommended prostate cancer screening only for a few thousand high-risk men with the BRCA2 gene mutation and a family history of cancer, concluding that mass screening would likely 'cause more harm than good'.
A treatment that targets the immune system has been reported to reduce symptoms in patients with major depressive disorder who are resistant to conventional antidepressants, supporting the depression-inflammation link.
The Trump administration's plan to relax drinking-water rules while discussing the destruction of 'forever chemicals' known as PFAS is being criticised by scientists, with concerns about inadequate destruction technologies and the renewed rise of health risks.